Why do we need an Asthma Revolution?
Asthma is responsible for a substantial burden of disease worldwide .
Around the world, 9−20% of patients with mild asthma experience asthma exacerbations annually [3−5] and in a study of 1,277 patients with mild asthma using a short-acting β2-agonist (SABA) as-needed, nearly 1 in 8 experienced a severe exacerbation over the course of a year .
Many patients with asthma do not have over the course of a year adequate control of their symptoms, risking preventable asthma attacks that result in significant physical and emotional burden and can be life threatening [6,7].
Patients of all ages, with asthma of all severities, are at risk of asthma attacks, including those with mild asthma and those who consider their asthma to be controlled [3−6,8].
The Asthma Revolution is here
The Asthma Revolution is a growing online community connecting you with other healthcare professionals who share a vision of transforming asthma care.
Asthma care is changing.
Look out for the Asthma Revolution in your country, and join to be a part of the change.
 The Global Asthma Network. The Global Asthma Report, 2018. Available from: http://www.globalasthmanetwork.org/publications/Global_Asthma_Report_2018.pdf.
 AstraZeneca Pharmaceuticals. Data on file. Annual rate of exacerbations globally (ID: SD-3010-ALL-0017).
 O’Byrne PM et al. N Engl J Med. 2018;378:1865–1876.
 Bateman ED et al. N Engl J Med. 2018;378:1877–1887.
 Suruki RY et al. BMC Pulm Med. 2017;17:74.
 Price D et al. NPJ Prim Care Respir Med. 2014;24:14009.
 Sastre J et al. World Allergy Organ J. 2016;9:13.